Epidemiological trends here have been deteriorating over recent days, Cecilia Müller announced yesterday at a press conference of the operative board responsible for handling the epidemic.
Müller noted that vaccinations are ongoing with the Pfizer-BioNTech, Moderna, AstraZeneca and Sputnik V jabs, while experts are still examining the Chinese Sinopharm vaccine, she said.
|
|